GTHX insider trading

G1 Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
451
Last 90 days
0
Buys / sells
4% / 41%
Market cap

GTHX insider activity at a glance

FilingIQ has scored 451 insider transactions for GTHX since May 17, 2017. The most recent filing in our index is dated Sep 18, 2024.

Across the full history, 16 open-market purchases and 183 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on GTHX insider trades is 57.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest GTHX Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for GTHX?
FilingIQ tracks 451 Form 4 insider transactions for GTHX (G1 Therapeutics, Inc.), covering filings from May 17, 2017 onwards. 0 of those were filed in the last 90 days.
Are GTHX insiders net buyers or net sellers?
Across the full Form 4 history for GTHX, 16 transactions (4%) were open-market purchases and 183 (41%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does GTHX insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

Methodology & sources

Every GTHX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.